Amgen (AMGN) Long-Term Debt Repayments (2009 - 2026)

Amgen's Long-Term Debt Repayments history runs 16 years deep, the most recent figure standing at $833.0 million for Q1 2026.

• In Q1 2026, Long-Term Debt Repayments fell 66.68% year-over-year to $833.0 million; the TTM figure through Mar 2026 stood at $3.3 billion (down 45.36% YoY), while the FY2025 annual figure was $5.0 billion, up 38.89% from the prior year.
• Long-Term Debt Repayments was $833.0 million for Q1 2026 at Amgen, down from $1.5 billion in the prior quarter.
• In the past five years, Long-Term Debt Repayments ranged from a high of $2.5 billion in Q1 2025 to a low of $704.0 million in Q1 2023.
• Historically, Long-Term Debt Repayments has averaged $1.4 billion across 4 years, with a median of $1.2 billion in 2024.
• The sharpest annual moves came in 2024 and 2026: Long-Term Debt Repayments jumped 193.33% in 2024, then tumbled 66.68% in 2026.
• A 4-year view of Long-Term Debt Repayments shows it stood at $750.0 million in 2023, then soared by 193.33% to $2.2 billion in 2024, then slumped by 31.82% to $1.5 billion in 2025, then plunged by 44.47% to $833.0 million in 2026.
• The last three Long-Term Debt Repayments figures came in at $833.0 million (Q1 2026), $1.5 billion (Q3 2025), and $1.0 billion (Q2 2025), per Business Quant data.